Latest News
- Study shows more effective method for detecting prostate cancer
A multidisciplinary team of UCLA physicians has found that a new method, which includes biopsy guided by magnetic resonance imaging, or MRI, can be used together with the traditional method to increase the rate of prostate cancer detection.
June 13, 2019 7:00 AM
detail - UCLA professor’s last gift will support research in cancer and stem cell biology
Shortly before financier and UCLA professor Roy Doumani passed away in March, he and his wife, Carol, contributed $5.25 million to advance research in cancer and stem cell biology at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.
June 12, 2019 10:00 AM
detail - Organic chemist named the UC Presidential Chair in Medicinal Chemistry
Michael Jung, UCLA distinguished professor of chemistry and biochemistry, has been named the University of California Presidential Chair in Medicinal Chemistry.
June 11, 2019 9:00 AM
detail - UCLA Health adopts Microsoft Azure to accelerate medical research and improve patient care
UCLA Health is deploying Microsoft cloud computing services to enable UCLA Health and the David Geffen School of Medicine to synthesize vast amounts of clinical and research data to speed medical discoveries and improve patient care.
June 10, 2019 8:00 AM
detail - Researchers identify three-drug combination that helps curb the growth of deadly type of skin cancer
A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.
June 06, 2019 8:00 AM
detail - Researcher receives grant to study cancer screenings for low-income people
Dr. Fola May has received an R03 grant from the National Institutes of Health and the National Cancer Institute.
June 03, 2019 10:30 AM
detail - Traditional chemotherapy still gold standard over new targeted therapy for HER2-positive breast cancers
Results of a phase 3 clinical trial by researchers at the UCLA Jonsson Comprehensive Cancer Center found that women with HER2-positive breast cancer had significantly better response rates, but more severe side effects, when they were treated with traditional neoadjuvant chemotherapy along with dual HER2-targeted blockade compared to a more novel approach using HER2-targeted chemotherapy plus HER2-targeted blockade.
June 03, 2019 7:45 AM
detail - Immunotherapy drug improves five-year survival rate of people with advanced lung cancer
In a study led by UCLA investigators, treatment with the immunotherapy drug pembrolizumab helped more than 15 percent of people with advanced non-small cell lung cancer live for at least five years — and 25 percent of patients whose tumor cells had a specific protein lived at least that long.
June 01, 2019 6:00 AM
detail - Adding ribociclib to hormone therapy extends lives of women with most common metastatic breast cancer
A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help premenopausal women with the most common type of breast cancer live longer than if they only receive the hormone therapy.
June 01, 2019 4:30 AM
detail - Prostate cancer research examines radiation protocol for the whole pelvis
Treating an aggressive disease is always challenging but improving the way therapies are applied can benefit patients by giving them a better outcome.
May 16, 2019 8:00 AM
detail - Urology professor elected to national association
Dr. Christopher Saigal has been elected to the American Association of Genitourinary Surgeons in recognition of his accomplishments in the field.
May 13, 2019 8:30 AM
detail - UCLA physician-scientist honored for advancing the field of oncology
Dr. Beth Karlan has been inducted into the 2019 class of Giants of Cancer Care in gynecologic malignancies by OncLive.
May 10, 2019 10:30 AM
detail - Professor receives grant to study how artificial intelligence could improve cancer diagnosis
Dr. Joann Elmore has been awarded a $375,000 Established Investigator Award from the Melanoma Research Alliance.
May 10, 2019 10:00 AM
detail - Scientists identify genes tied to increased risk of ovarian cancer
A team of researchers at the UCLA Jonsson Comprehensive Cancer Center, Cedars-Sinai Cancer, and Dana-Farber Cancer Institute have newly identified 34 genes that are associated with an increased risk for developing earliest-stage ovarian cancer.
May 01, 2019 8:00 AM
detail - New research could prevent jaw damage for cancer patients in need of oral surgery
UCLA researchers are co-leading a new pre-clinical study that could prevent patients treated for cancer or osteoporosis from experiencing jawbone damage as a result of oral surgery.
May 01, 2019 8:00 AM
detail - $4.6 million grant funds clinical trial of stem cell immunotherapy for metastatic sarcoma and other hard-to-treat cancers
UCLA scientists have been awarded a $4.6 million grant from CIRM to support a phase I clinical trial of a novel treatment for advanced sarcomas and other cancers with a specific tumor marker called NY-ESO-1.
April 29, 2019 12:00 PM
detail - UCLA researchers to present on latest advancements in immunotherapy and combination therapies at annual ASCO meeting
Physicians and scientists from UCLA’s Jonsson Comprehensive Cancer Center will be joining more than 32,000 scientists, clinicians, advocates and industry luminaries from institutions around the world to discuss the most recent advancements in cancer research at the American Society of Clinical Oncology (ASCO) annual meeting.
April 29, 2019 8:00 AM
detail - Physician-scientist recognized as a thought leader in cancer genomics and immunotherapy
Dr. Antoni Ribas, a renowned physician-scientist and professor of medicine in the David Geffen School of Medicine at UCLA, was selected by Agilent Technologies for their prestigious Thought Leader Award.
April 17, 2019 8:00 AM
detail - Artificial intelligence performs as well as experienced radiologists in detecting prostate cancer
UCLA researchers have developed a new artificial intelligence system to help radiologists improve their ability to diagnose prostate cancer.
April 16, 2019 6:00 AM
detail - Recently identified gene mutation which predicts increased risk of cancers has profound effect on normal breast cells
In a study published online in Springer Nature, UCLA researchers have proven the impact of a new class of gene mutations on normal cellular biology.
April 15, 2019 8:00 AM
detail